BC Biotech's Board of Directors Appoint Sub-Committee Chairs and Board Representatives

BC Biotech's Committees have been structured to reflect the key initiatives outlined in our Strategic Plan:

• Advocacy – undertaking relevant public policy initiatives and working with the policy makers to strengthen the biotechnology sector
• Promoting and increasing the profile of BC’s biotechnology industry within and outside Canada
• Development and support of our human capital
• Facilitating economic development in British Columbia through the biotechnology industry

BC Biotech's Committees and Board Representatives are:

Public Policy Committee

David Hall, Chair - Angiotech Pharmaceuticals Inc.
Hector MacKay-Dunn, QC - Farris, Vaughan, Wills & Murphy LLP
Bill Newell - QLT Inc.
Bob Sindelar - UBC Faculty of Pharmaceutical Sciences

Communications Committee

Joe Garcia, Chair - McCarthy Tétrault
Patrick Wolfe - Raymond James
John DeLucchi - PricewaterhouseCoopers

Human Capital Committee

David Main, Chair

Scott Cormack - OncoGenex Technologies
Natalie Dakers - Centre for Drug Research and Development
Jim DeMesa - MIGENIX Inc.

Additional members for each committee will be sought in the coming month.

For more information on our committees and how to be involved, please contact Barry Gee, Director of Operations and Communications at (604) 602-5226 or bgee@bcbiotech.ca